Wall Street Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $621K | Sell |
16,400
-112,000
| -87% | -$4.24M | 0.41% | 89 |
|
|
2016
Q3 | $4.85M | Buy |
128,400
+107,900
| +526% | +$4.07M | 1.65% | 2 |
|
|
2016
Q2 | $361K | Hold |
20,500
| – | – | 0.14% | 152 |
|
|
2016
Q1 | $249K | Hold |
20,500
| – | – | 0.1% | 203 |
|
|
2015
Q4 | $499K | Hold |
20,500
| – | – | 0.14% | 206 |
|
|
2015
Q3 | $364K | Sell |
20,500
-223,500
| -92% | -$3.97M | 0.07% | 258 |
|
|
2015
Q2 | $4.31M | Sell |
244,000
-9,700
| -4% | -$171K | 0.41% | 85 |
|
|
2015
Q1 | $7.95M | Sell |
253,700
-8,700
| -3% | -$273K | 0.75% | 35 |
|
|
2014
Q4 | $7.66M | Sell |
262,400
-4,400
| -2% | -$128K | 0.73% | 43 |
|
|
2014
Q3 | $5.52M | Sell |
266,800
-34,400
| -11% | -$712K | 0.57% | 67 |
|
|
2014
Q2 | $7.46M | Buy |
301,200
+2,100
| +0.7% | +$52K | 0.64% | 53 |
|
|
2014
Q1 | $6.34M | Sell |
299,100
-11,400
| -4% | -$242K | 0.52% | 74 |
|
|
2013
Q4 | $5.58M | Buy |
+310,500
| New | +$5.58M | 0.46% | 76 |
|